CYP1B1 and prostate neoplasm: However, its expression is elevated in tumors compared to normal tissues [5–8], especially in hormone-related cancers including breast, ovary, and prostate tumors [9–11] and the pre-disposing potential of CYP1B1 for various cancers also has been widely reported [12–14].